Výsledky vyhledávání

Akademický článek

Leber hereditary optic neuropathy in Slovenia: quality of life and costs from patient perspective.

Autor: Hawlina M; Eye Hospital, University Medical Centre Ljubljana, Ljubljana, Slovenia., Kovač L; Eye Hospital, University Medical Centre Ljubljana, Ljubljana, Slovenia., Breciková K; CEEOR s.r.o., Prague, Czechia. katarina.brecikova@ceeor.com., Žigmond J; Department of Biomedical Technology, Faculty of Biomedical Engineering, Czech Technical University Prague, Kladno, Czechia., Rogalewicz V; Department of Biomedical Technology, Faculty of Biomedical Engineering, Czech Technical University Prague, Kladno, Czechia., Tichopád A; Department of Biomedical Technology, Faculty of Biomedical Engineering, Czech Technical University Prague, Kladno, Czechia., Višňanský M; Department of Pharmacy and Social Pharmacy, University of Veterinary Medicine and Pharmacy Košice, Košice, Slovakia.; Department of Public Economics, Faculty of Economics and Administration, Masaryk University Brno, Brno, Czechia., Šarkanová I; CEEOR s.r.o., Prague, Czechia.; Department of Biomedical Technology, Faculty of Biomedical Engineering, Czech Technical University Prague, Kladno, Czechia.

Publikováno v: Orphanet journal of rare diseases [Orphanet J Rare Dis] 2024 Aug 30; Vol. 19 (1), pp. 318. Date of Electronic Publication: 2024 Aug 30.

Zobrazit plný text záznamu

Plný text ve formátu HTML

Akademický článek

Leber hereditary optic neuropathy in Czechia and Slovakia: Quality of life and costs from patient perspective.

Autor: Bušányová B; Department of Paediatric Ophthalmology of the Faculty of Medicine, Comenius University Bratislava, And the National Institute of Children's Diseases in Bratislava, Slovakia., Vajter M; Department of Ophthalmology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Czech Republic., Kelifová S; Department of Paediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital in Prague, Czech Republic., Lišková P; Department of Ophthalmology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Czech Republic.; Department of Paediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital in Prague, Czech Republic., Miková H; Ophthalmological Outpatient Clinic, University Hospital - St. Michael's Hospital, Bratislava, Slovakia., Breciková K; CEEOR s.r.o, Prague, Czech Republic., Žigmond J; Department of Biomedical Technology, Faculty of Biomedical Engineering, Czech Technical University in Prague, Kladno, Czech Republic., Rogalewicz V; Department of Biomedical Technology, Faculty of Biomedical Engineering, Czech Technical University in Prague, Kladno, Czech Republic., Tichopád A; Department of Biomedical Technology, Faculty of Biomedical Engineering, Czech Technical University in Prague, Kladno, Czech Republic., Višňanský M; Department of Pharmacy and Social Pharmacy, University of Veterinary Medicine and Pharmacy in Košice, Slovakia.; Department of Public Economics, Faculty of Economics and Administration, Masaryk University in Brno, Czech Republic., Šarkanová I; Department of Biomedical Technology, Faculty of Biomedical Engineering, Czech Technical University in Prague, Kladno, Czech Republic.

Publikováno v: Heliyon [Heliyon] 2024 May 31; Vol. 10 (11), pp. e32296. Date of Electronic Publication: 2024 May 31 (Print Publication: 2024).

Zobrazit plný text záznamu

Akademický článek

Adherence to application technique of inhaled corticosteroid in patients with asthma and COVID-19 improves outcomes.

Autor: Tichopád A; Department of Biomedical Technology, Czech Technical University in Prague Faculty of Biomedical Engineering, Kladno, Czech Republic., Žigmond J; Department of Biomedical Technology, Czech Technical University in Prague Faculty of Biomedical Engineering, Kladno, Czech Republic., Jeseňák M; Department of Pulmonology and Phthisiology, Comenius University in Bratislava Jessenius Faculty of Medicine in Martin, Martin, Slovakia., Solovič I; National Institute of Tuberculosis, Lung Diseases and Thoracic Surgery, Vyšné Hágy, Slovakia, Vyšné Hágy, Slovakia, Vyšné Hágy, Slovakia.; Faculty of Health, Catholic University in Ruzomberok, Ruzomberok, Slovakia., Breciková K; CEEOR spol. s.r.o, Prague, Czech Republic., Rybář M; Department of Biomedical Technology, Czech Technical University in Prague Faculty of Biomedical Engineering, Kladno, Czech Republic., Rožánek M; Department of Biomedical Technology, Czech Technical University in Prague Faculty of Biomedical Engineering, Kladno, Czech Republic., Sedlák V; Department of Respiratory Medicine, Fakultní Nemocnice Hradec Králové, Hradec Králové, Czech Republic vratislav.sedlak@fnhk.cz.

Publikováno v: BMJ open respiratory research [BMJ Open Respir Res] 2024 Jan 06; Vol. 11 (1). Date of Electronic Publication: 2024 Jan 06.

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Akademický článek

Effectiveness, Adverse Events, and Immune Response Following Double Vaccination with BNT162b2 in Staff at the National Comprehensive Cancer Center (NCCC).

Autor: Palacka P; 2nd Department of Oncology, Faculty of Medicine, Comenius University, 833 10 Bratislava, Slovakia.; National Cancer Institute, 833 10 Bratislava, Slovakia., Pol'anová M; Central-European Biotech Institute, Riečna 162/4, 811 02 Bratislava, Slovakia., Svobodová A; Department of Clinical Biochemistry, National Cancer Institute, 833 10 Bratislava, Slovakia., Žigmond J; Central-European Biotech Institute, Riečna 162/4, 811 02 Bratislava, Slovakia., Zanchetta K; National Cancer Institute, 833 10 Bratislava, Slovakia.; Department of Nursing, Faculty of Health Care and Social Work, Trnava University, 917 01 Trnava, Slovakia., Gombárová V; Hospital Pharmacy, National Cancer Institute, 833 10 Bratislava, Slovakia., Vulganová M; Central-European Biotech Institute, Riečna 162/4, 811 02 Bratislava, Slovakia., Slopovský J; 2nd Department of Oncology, Faculty of Medicine, Comenius University, 833 10 Bratislava, Slovakia.; National Cancer Institute, 833 10 Bratislava, Slovakia., Obertová J; 2nd Department of Oncology, Faculty of Medicine, Comenius University, 833 10 Bratislava, Slovakia.; National Cancer Institute, 833 10 Bratislava, Slovakia., Drgoňa Ľ; National Cancer Institute, 833 10 Bratislava, Slovakia.; Department of Oncohematology, Faculty of Medicine, Comenius University, 833 10 Bratislava, Slovakia., Mego M; 2nd Department of Oncology, Faculty of Medicine, Comenius University, 833 10 Bratislava, Slovakia.; National Cancer Institute, 833 10 Bratislava, Slovakia., Pechan J; Department of Oncosurgery, Faculty of Medicine, Slovak Medical University, 833 10 Bratislava, Slovakia.

Publikováno v: Vaccines [Vaccines (Basel)] 2022 Apr 04; Vol. 10 (4). Date of Electronic Publication: 2022 Apr 04.

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání